Leronlimab (anti-CCR5)

Catalog No.A2040 Synonyms: PRO 140; Vyrologix

For research use only.
Not for use in humans.

Leronlimab (anti-CCR5) (PRO 140; Vyrologix)is a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy. It is being investigated as a potential therapy in the treatment of HIV infection.

Leronlimab (anti-CCR5)

Purity & Quality Control

Choose Selective CCR Inhibitors

Biological Activity

Description Leronlimab (anti-CCR5) (PRO 140; Vyrologix)is a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy. It is being investigated as a potential therapy in the treatment of HIV infection.

Protocol (from reference)

Product Details

CAS No. 674782-26-4
Molecular Weight 146.7 KD
Formulation PBS Buffer, PH 7.4
Isotype Human IgG4
Application Leronlimab (anti-CCR5)
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Sterility 0.2 μM filtered

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Leronlimab (anti-CCR5) | Leronlimab (anti-CCR5) supplier | purchase Leronlimab (anti-CCR5) | Leronlimab (anti-CCR5) cost | Leronlimab (anti-CCR5) manufacturer | order Leronlimab (anti-CCR5) | Leronlimab (anti-CCR5) distributor